Avanza Fonder’s Arcellx ACLX Stock Holding History

Avanza Fonder’s Portfolio ACLX Stock Details ACLX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-2,003	Closed	-$131K	–	486
2025 Q4	$131K	Buy	2,003 +784	+64%	+$62.5K	﹤0.01%	449
2025 Q3	$100K	Hold	1,219	–	–	﹤0.01%	412
2025 Q2	$80.3K	Sell	1,219 -424	-26%	-$26.4K	﹤0.01%	418
2025 Q1	$110K	Sell	1,643 -755	-31%	-$51.1K	﹤0.01%	432
2024 Q4	$184K	Buy	+2,398	New	+$207K	0.01%	400

Other funds holding ACLX

Gilead Sciences Foster City, California $2.12B AUM 143.53% 1-Year Est. Return

PBA

Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

NMC

NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return

PCM

Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

SOCM

SR One Capital Management Wayne, Pennsylvania $915M AUM 209.71% 1-Year Est. Return

Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return

HBK Investments Dallas, Texas $9.85B AUM 55.6% 1-Year Est. Return

Avanza Fonder's ACLX Position: Q1 2026 in Review

Avanza Fonder sold out of Arcellx (ACLX) in Q1 2026, closing a stake of 2,003 shares — an estimated $131K sold.

Avanza Fonder first reported a position in ACLX in Q4 2024 and held it in 5 quarters. The position peaked at $184K in Q4 2024. 239 funds tracked by Wall St. Rank hold ACLX as of Q1 2026.

Avanza Fonder reported no remaining Arcellx position as of Q1 2026 after selling out during the quarter.
Avanza Fonder sold 2,003 Arcellx shares in Q1 2026, an estimated $131K.
Avanza Fonder first reported a position in Arcellx in Q4 2024 and held it in 5 quarters.
Avanza Fonder's Arcellx position peaked at $184K in Q4 2024.
239 funds tracked by Wall St. Rank held Arcellx as of Q1 2026.

Based on Avanza Fonder's 13F filing for Q1 2026, filed 15 Apr 2026.